EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Association of proton pump inhibitor use with outcome of patients with recurrent glioblastoma

Emilie Le Rhun, Debaleena Sain, Martin van den Bent, Enrico Franceschi, Ghazaleh Tabatabai, Wolfgang Wick, Matthias Preusser, Thierry Gorlia, Michael Weller

European Journal of Cancer · 2026-02 · 235 · 116225

DOI: 10.1016/j.ejca.2026.116225 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift European Journal of Cancer, 2026-02. Verfasst von Emilie Le Rhun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland; University of Zurich, Zurich, Switzerland. Electronic address…. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioblastoma, Neoplasm Recurrence, Local, Proton Pump Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: European Organisation for Research and Treatment of Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsGlioblastomaNeoplasm Recurrence, LocalProton Pump InhibitorsAdultAgedFemaleHumansMaleMiddle AgedPrognosisProgression-Free SurvivalRandomized Controlled Trials as TopicClinical Trials, Phase II as TopicDNA Modification MethylasesTumor Suppressor ProteinsDNA Repair Enzymes

Stichwörter der Autor:innen

ALDH1A1OutcomePPIPrognosisSteroids

Substanzen

MGMT protein, humanProton Pump InhibitorsDNA Modification MethylasesTumor Suppressor ProteinsDNA Repair Enzymes

Autor:innen und Institutionen

  • Department of Medical Oncology and Hematology, University Hospital Zurich, Switzerland; University of Zurich, Zurich, Switzerland. Electronic address: emilie.lerhun@usz.ch.
  • EORTC Headquarters, Brussels, Belgium.
  • The Brain Tumour Center at the Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Nervous System Medical Oncology Department, IRCCS Instituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
  • Department of Neurology & Neuro-Oncology, Hertie Institute for Clinical Brain Research, Center for Neurooncology, Comprehensive Cancer Center, German Cancer Consortium (DKTK), Partner site Tübingen, University Hospital…
  • Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Förderung

  • European Organisation for Research and Treatment of Cancer

Zitieren

APA

Le Rhun, E., Sain, D., van den Bent, M., Franceschi, E., Tabatabai, G., Wick, W., Preusser, M., Gorlia, T., & Weller, M. (2026). Association of proton pump inhibitor use with outcome of patients with recurrent glioblastoma. European Journal of Cancer, 235, 116225. https://doi.org/10.1016/j.ejca.2026.116225

Vancouver

Le Rhun E, Sain D, van den Bent M, Franceschi E, Tabatabai G, Wick W, et al. Association of proton pump inhibitor use with outcome of patients with recurrent glioblastoma. European Journal of Cancer. 2026;235:116225. doi:10.1016/j.ejca.2026.116225

BibTeX
@article{LeRhun2026,
  author = {Le Rhun, Emilie and Sain, Debaleena and van den Bent, Martin and Franceschi, Enrico and Tabatabai, Ghazaleh and Wick, Wolfgang and Preusser, Matthias and Gorlia, Thierry and Weller, Michael},
  title = {Association of proton pump inhibitor use with outcome of patients with recurrent glioblastoma},
  journal = {European Journal of Cancer},
  year = {2026},
  volume = {235},
  pages = {116225},
  doi = {10.1016/j.ejca.2026.116225}
}
Kostenlos starten →